2018 -
now Chief Operating Officer @ EpiDestiny, Inc.
2018 -
2018 VP Drug Development @ EpiDestiny, Inc.
2011 -
2018 Exec. Dir. Clinical R and D @ Teva Pharmaceutical (Formally Watson Pharmaceuticals, Actavis, and Allergan)
2011 -
2015 Exec Dir Clinical R and D @
2005 -
2011 Exec. Dir. Clinical Pharmacology @
2003 -
2005 Sr. Dir @
2001 -
2004 Dir @
1986 -
2001 Director @
1988 -
1990 Director @
1985 -
1986 Pharmacokinetics @ The Upjohn Co.
Henry Lau Education
University of Michigan
PhD (Pharmaceutics)
1981
-
1986
Northeastern University
BS (Pharmacy)
1974
-
1979
Henry Lau Skills
Molecular Biology
PLC
Clinical Research
Clinical Pharmacology
Project Management
Clinical Trials
Pharmaceuticals
Regulatory Affairs
R
Pharmaceutical Industry
Clinical Development
R&D
Pharmacokinetics
Hospitals
Henry Lau Summary
Henry Lau, based in Bridgewater, NJ, US, is currently a Chief Operating Officer at EpiDestiny, Inc.. Henry Lau brings experience from previous roles at EpiDestiny, Inc., Teva Pharmaceutical (Formally Watson Pharmaceuticals, Actavis, and Allergan), Actavis and Celgene. Henry Lau holds a 1981 - 1986 PhD in Pharmaceutics @ University of Michigan. With a robust skill set that includes Molecular Biology, PLC, Clinical Research, Clinical Pharmacology, Project Management and more. Henry Lau has 1 emails and 3 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.